Digitisation | June 22, 2022
Iktos and Zealand Pharma to develop AI technology for peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Glenmark is the first company in India to market the innovative FDC of Indacaterol
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
_256_384.png)
Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities
Subscribe To Our Newsletter & Stay Updated
